SCHEMBL1820562

SCHEMBL1820562

CC(CCCCN1CCOCC1)C(N)C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.46
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
KEAP1 Q14145 1/20 0.42
KDM4E B2RXH2 4/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
PAOX Q6QHF9 1/20 0.40
GLA P06280 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TSHR P16473 2/20 0.39
HRH3 Q9Y5N1 1/20 0.37
MAPK1 P28482 1/20 0.37
HIF1A Q16665 1/20 0.37
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1818750 1.00 GAA (0.46) GAAALDH1A1SMN1; SMN2KEAP1KDM4E
SCHEMBL2015998 1.00 GAA (0.46) GAAALDH1A1SMN1; SMN2KEAP1KDM4E
SCHEMBL2011097 1.00 GAA (0.46) GAAALDH1A1SMN1; SMN2KEAP1KDM4E
SCHEMBL17518331 0.80 GAA (0.47) GAAALDH1A1SMN1; SMN2KEAP1KDM4E
SCHEMBL17518251 0.79 GAA (0.46) GAAALDH1A1SMN1; SMN2KEAP1KDM4E
SCHEMBL2201068 0.78 GAA (0.57) GAAALDH1A1SMN1; SMN2KEAP1KDM4E
SCHEMBL17518390 0.75 GAA (0.48) GAAALDH1A1SMN1; SMN2KEAP1KDM4E
SCHEMBL6472014 0.75 GAA (0.50) GAAALDH1A1SMN1; SMN2KEAP1KDM4E
SCHEMBL14562932 0.74 ALDH1A1 (0.50) GAAALDH1A1SMN1; SMN2KEAP1KDM4E
SCHEMBL4405073 0.74 ALDH1A1 (0.50) GAAALDH1A1SMN1; SMN2KEAP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2498782-A1 CRYSTALLINE FORMS OF NEUROTROPHIN MIMETIC COMPOUNDS AND THEIR SALTS Pharmatrophix Inc. (US) 2012-09-19 EP disclosed
WO-2011060262-A1 CRYSTALLINE FORMS OF NEUROTROPHIN MIMETIC COMPOUNDS AND THEIR SALTS PHARMATROPHIX, INC. (US) 2011-05-19 WO disclosed